David Wang‐Iverson

1.2k total citations
19 papers, 931 citations indexed

About

David Wang‐Iverson is a scholar working on Spectroscopy, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, David Wang‐Iverson has authored 19 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Spectroscopy, 6 papers in Molecular Biology and 4 papers in Analytical Chemistry. Recurrent topics in David Wang‐Iverson's work include Analytical Chemistry and Chromatography (10 papers), Chromatography in Natural Products (4 papers) and Microfluidic and Capillary Electrophoresis Applications (4 papers). David Wang‐Iverson is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Chromatography in Natural Products (4 papers) and Microfluidic and Capillary Electrophoresis Applications (4 papers). David Wang‐Iverson collaborates with scholars based in United States, Germany and Malaysia. David Wang‐Iverson's co-authors include Adrienne A. Tymiak, Yingru Zhang, Dauh‐Rurng Wu, Eugene Ivashkiv, A. Arthur Sugerman, Brian N. Swanson, Henry Pan, Arthur R. DeVault, John D. Baxter and Wolfgang Dillmann and has published in prestigious journals such as Endocrinology, Drug Discovery Today and Toxicology and Applied Pharmacology.

In The Last Decade

David Wang‐Iverson

18 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Wang‐Iverson United States	13	366	256	228	188	117	19	931
Ralf Nilsson Sweden	15	615 1.7×	158 0.6×	191 0.8×	93 0.5×	58 0.5×	25	1.3k
Harri G. Ramjit United States	16	548 1.5×	77 0.3×	135 0.6×	37 0.2×	32 0.3×	47	1.1k
Yi Zheng China	19	370 1.0×	93 0.4×	84 0.4×	41 0.2×	61 0.5×	74	966
Thomas S. McDonald United States	16	216 0.6×	244 1.0×	45 0.2×	66 0.4×	166 1.4×	27	610
P Padieu France	15	290 0.8×	158 0.6×	139 0.6×	168 0.9×	38 0.3×	73	817
Rao N. V. S. Mamidi United States	21	439 1.2×	33 0.1×	183 0.8×	261 1.4×	39 0.3×	45	1.1k
Hisashi Shinkai Japan	14	573 1.6×	44 0.2×	498 2.2×	436 2.3×	33 0.3×	27	1.6k
Wataru Takasaki Japan	19	479 1.3×	104 0.4×	67 0.3×	28 0.1×	37 0.3×	66	1.0k
Keyang Xu China	26	1.0k 2.8×	279 1.1×	50 0.2×	73 0.4×	133 1.1×	82	2.1k

Countries citing papers authored by David Wang‐Iverson

Since Specialization

Citations

This map shows the geographic impact of David Wang‐Iverson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wang‐Iverson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wang‐Iverson more than expected).

Fields of papers citing papers by David Wang‐Iverson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wang‐Iverson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wang‐Iverson. The network helps show where David Wang‐Iverson may publish in the future.

Co-authorship network of co-authors of David Wang‐Iverson

This figure shows the co-authorship network connecting the top 25 collaborators of David Wang‐Iverson. A scholar is included among the top collaborators of David Wang‐Iverson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wang‐Iverson. David Wang‐Iverson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wu, Steven T., Jochem Gokemeijer, Aberra Fura, et al.. (2011). Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies. Analytical and Bioanalytical Chemistry. 402(3). 1229–1239. 47 indexed citations

Goodenough, Angela K., Joelle M. Onorato, Zheng Ouyang, et al.. (2011). Quantification of 4-Beta-Hydroxycholesterol in Human Plasma Using Automated Sample Preparation and LC-ESI-MS/MS Analysis. Chemical Research in Toxicology. 24(9). 1575–1585. 40 indexed citations

Qian‐Cutrone, Jingfang, Richard A. Hartz, Vijay T. Ahuja, et al.. (2010). Chiral separation of potent corticotropin-releasing factor-1 receptor antagonists by supercritical fluid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 54(3). 602–606. 4 indexed citations

Chen, Guodong, Bethanne M. Warrack, Angela K. Goodenough, et al.. (2010). Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. Drug Discovery Today. 16(1-2). 58–64. 48 indexed citations

Liu, Peiran, Bethanne M. Warrack, Wei Wu, et al.. (2010). A tris (2-carboxyethyl) phosphine (TCEP) related cleavage on cysteine-containing proteins. Journal of the American Society for Mass Spectrometry. 21(5). 837–844. 59 indexed citations

Wang, Jian, Anne‐Françoise Aubry, Georgia Cornelius, et al.. (2010). Importance of mobile phase and injection solvent selection during rapid method development and sample analysis in drug discovery bioanalysis illustrated using convenient multiplexed LC-MS/MS. Analytical Methods. 2(4). 375–375. 6 indexed citations

Zhang, Yong, et al.. (2008). Development and implementation of a stereoselective normal-phase liquid chromatography–tandem mass spectrometry method for the determination of intrinsic metabolic clearance in human liver microsomes☆. Journal of Chromatography B. 875(1). 154–160. 4 indexed citations

Qian‐Cutrone, Jingfang, et al.. (2008). Separation of maxi-K channel opening 3-substitued-4-arylquinolinone atropisomers by enantioselective supercritical fluid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 48(4). 1120–1126. 10 indexed citations

Zhang, Yingru, Jun Dai, David Wang‐Iverson, & Adrienne A. Tymiak. (2007). Simulated moving columns technique for enantioselective supercritical fluid chromatography. Chirality. 19(9). 683–692. 12 indexed citations

10.

Zhang, Yingru, Dauh‐Rurng Wu, David Wang‐Iverson, & Adrienne A. Tymiak. (2005). Enantioselective chromatography in drug discovery. Drug Discovery Today. 10(8). 571–577. 160 indexed citations

11.

Wu, Steven T., Atsu Apedo, David Wang‐Iverson, et al.. (2004). High‐throughput chiral analysis of albuterol enantiomers in dog plasma using on‐line sample extraction/polar organic mode chiral liquid chromatography with tandem mass spectrometric detection. Rapid Communications in Mass Spectrometry. 18(21). 2531–2536. 18 indexed citations

12.

Humphreys, W. Griffith, Mary T. Obermeier, Joel C. Barrish, et al.. (2003). Application of structure–metabolism relationships in the identification of a selective endothelin A antagonist, BMS-193884, with favourable pharmacokinetic properties. Xenobiotica. 33(11). 1109–1123. 1 indexed citations

13.

Das, Jagabandhu, S. David Kimball, Steven E. Hall, et al.. (2002). Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664. Bioorganic & Medicinal Chemistry Letters. 12(1). 45–49. 10 indexed citations

14.

Trost, Susanne U., Eric A. Swanson, Bernd Gloss, et al.. (2000). The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity¹. Endocrinology. 141(9). 3057–3064. 195 indexed citations

15.

Palmoski, Marshall J., et al.. (1995). In Vitro Myotoxicity of the 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors, Pravastatin, Lovastatin, and Simvastatin, Using Neonatal Rat Skeletal Myocytes. Toxicology and Applied Pharmacology. 131(1). 163–174. 110 indexed citations

16.

Wang‐Iverson, David, Mark E. Arnold, Mohammed Jemal, & Allen I. Cohen. (1992). Determination of SQ 33,600, a phosphinic acid containing HMG CoA reductase inhibitor, in human serum by high-performance liquid chromatography combined with ionspray mass spectrometry. Journal of Mass Spectrometry. 21(4). 189–194. 24 indexed citations

17.

Triscari, Joseph, et al.. (1991). Pharmacokinetic interaction between propranolol and the HMG‐CoA reductase inhibitors pravastatin and lovastatin.. British Journal of Clinical Pharmacology. 31(6). 665–670. 37 indexed citations

18.

Pan, Henry, Arthur R. DeVault, David Wang‐Iverson, et al.. (1990). Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin. The Journal of Clinical Pharmacology. 30(12). 1128–1135. 130 indexed citations

19.

Wang‐Iverson, David, Eugene Ivashkiv, Mohammed Jemal, & Allen I. Cohen. (1989). Determination of lovastatin acid in serum by gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry. 3(5). 132–134. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact